• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Commercialization deals

Hand reaching for juice on grocery store shelf
Biotech

Genmab buys 2nd antibody from Scancell in deal worth up to $630M

Scancell can earn up to $630 million from the new sale if Genmab spins the antibody into drug products across all defined modalities.
Darren Incorvaia Dec 4, 2024 11:55am
Audience at rock concert

Novartis inks $150M deal for autoimmune molecular glue

Oct 28, 2024 7:00am
cash runway cash airplane extend deal earnings

Coya taps familiar friend Dr. Reddy's to commercialize ALS med

Dec 6, 2023 11:20am
Graphic image of the US from space during the night with lights shining across the country

Santhera offloads North American rights for DMD med to Catalyst

Jun 20, 2023 9:53am
Senseonics

Ascensia Diabetes Care launches Eversense's 6-month CGM system

Apr 4, 2022 10:45am
handshake

Capricor, Nippon ink $705M biobucks deal for phase 3 DMD therapy

Jan 25, 2022 5:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings